Pulmonary vascular diseases such as pulmonary embolism (PE) and pulmonary hypertension (PH) and their effects on right heart function contribute markedly to the global burden of chronic respiratory disease. The burden of pulmonary vascular diseases ( figures 1 and 2 ) is certainly underestimated and merits greater attention from the medical community. Better characterisation and management of patients is needed in order to improve disease outcomes.

See the entire Pulmonary vascular disease Chapter